Identix Experiencing Growing Momentum in Healthcare Market for Biometric Authentication Systems & Solutions.MINNETONKA, Minn. -- Receives Purchase Orders Valued at Approximately $1.4 Million for Deployment of Fingerprint Biometric Authentication See biometrics. Solutions into Hospitals and Healthcare Agencies Identix Incorporated (Nasdaq:IDNX IDNX Integrated Digital Network Exchange IDNX Integrated Data Network Exchange ) said today that it is seeing growing traction for the Company's biometric authentication technology in the healthcare market. Identix is partnered with Sentillion, Inc., a leading provider of single sign-on An identification system that lets users log into multiple Web sites on the Internet with one username and password. Single sign-on systems are also used within an enterprise, enabling users to access all authorized resources in the local network using the same username and password. solutions for healthcare, to take biometric single sign-on solutions into the healthcare industry. Together, Identix and Sentillion have delivered their combined biometric single sign-on solutions to more than 21 healthcare institutions across North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . Driven by the growing need for heightened security and the increasingly important requirement for better identification prior to granting access to PCs, company applications and healthcare institution and patient information, Identix perceives that leading healthcare companies may be increasing adoption of biometric authentication solutions to safeguard sensitive information. During its fiscal 2006 first quarter ending September 30, 2005, Identix received purchase orders for Healthcare deployments for its BioLogon(R) authentication (1) Verifying the integrity of a transmitted message. See message integrity, e-mail authentication and MAC. (2) Verifying the identity of a user logging into a network. software and from channel partners that integrate or embed Identix' enabling BioEngine(R) authentication technologies and accompanying single finger readers representing more than 35,000 seat licenses. The total value of these purchase orders is approximately $1.4 million. Identix said it expects to recognize approximately half of this revenue in its fiscal 2006 first quarter, with the remainder expected to be recognized in its fiscal 2006 second quarter ending December 31, 2005. "We believe the validation and adoption of biometric technology by governments throughout the world is beginning to spill over Verb 1. spill over - overflow with a certain feeling; "The children bubbled over with joy"; "My boss was bubbling over with anger" bubble over, overflow seethe, boil - be in an agitated emotional state; "The customer was seething with anger" 2. into the enterprise and commercial markets," said Identix President & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Dr. Joseph J. Atick. "This is an expected, yet important development; one which we believe may mark the beginning of commercial business beginning to provide meaningful revenue streams for the biometrics industry. "We believe the emergence of meaningful revenue streams in the commercial space, such as these recent healthcare orders, is an excellent complement to the solid growth we expect to continue to see in the federal, state & local and international government markets for identification systems and solutions," Atick continued, "Identix has invested hundreds of man years in developing key enabling components for biometric authentication. We believe Identix continues to be uniquely positioned to capitalize on Cap´i`tal`ize on` v. t. 1. To turn (an opportunity) to one's advantage; to take advantage of (a situation); to profit from; as, to capitalize on an opponent's mistakes s>. this development in the commercial space, as our multi-biometric offerings include one-to-one and one-to-many authentication technology that can be an excellent fit with the growing need to protect access to data via biometric authentication. Additionally, because we are not providing an end-to-end solution (jargon) end-to-end solution - (E2ES) A term that suggests that the supplier of an application program or system will provide all the hardware and/or software components and resouces to meet the customer's requirement and no other supplier need be involved. Compare: turn-key solution. for these markets, our core finger and face algorithms and application technology is a natural choice for channel owners such as Sentillion, as well as OEMs and other channel owners and other solutions companies that are looking to add biometric technologies authentication to their offerings. Sentillion has done an excellent job providing the healthcare industry with a multitude of robust, highly scalable and secure single sign-on solutions and we look forward to continuing to work closely with them to expand the breadth of both companies' offerings." About BioLogon Providing fingerprint and password support and designed to integrate seamlessly into a network's OS for central administration, configuration and maintenance of user account and security policies, BioLogon offers complete multi-factor authentication solution. BioLogon accepts multiple user account login Signing in and gaining access to a network server, Web server or other computer system. The process (the noun) is a "login" or "logon," while the act of doing it (the verb) is to "log in" or to "log on. methods, including biometrics and PIN combinations, enabling increased security, lower administrative costs administrative costs, n.pl the overhead expenses incurred in the operation of a dental benefits program, excluding costs of dental services provided. , and added convenience. About Sentillion Sentillion provides identity and access management solutions to the healthcare industry. Sentillion's Vergence vergence /ver·gence/ (ver´jens) a disjunctive reciprocal rotation of both eyes so that the axes of fixation are not parallel; the kind of vergence is indicated by a prefix, e.g., convergence, divergence. (R) product suite enables healthcare organizations to know who their users are, help them be productive, guard their systems and protect their patients. The Vergence product suite includes user provisioning The ability for customers to change voice and data services from their carriers online without having to place the order with a human representative. Web-based user provisioning lets you add and delete services and features from your browser. See automated provisioning. , strong authentication, single sign-on, clinical context management and privacy management. Sentillion was named the leading vendor for healthcare single sign-on for three consecutive years by IDC Research and was the recipient of the Frost & Sullivan 2004 Customer Value Enhancement Award in Healthcare. Sentillion is a privately held company privately held company A firm whose shares are held within a relatively small circle of owners and are not traded publicly. headquartered in Andover, Mass. For more information, visit Sentillion at www.sentillion.com. Identix, BioLogon and BioEngine are trademarks or registered trademarks of Identix Incorporated in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and other countries. About Identix Incorporated Identix Incorporated (Nasdaq:IDNX) is the world's leading multi-biometric technology company. Identix provides fingerprint, facial and skin biometric technologies, as well as systems, and critical system components that empower the identification of individuals in large-scale ID and ID management programs. The Company's offerings include live scan systems and services for biometric data capture, mobile systems for on-the-spot ID, and backend standards-based modules and software components for biometric matching and data mining. Identix products are used to conduct background checks, speed travel and commerce via secure identification documents, prevent identity fraud in large-scale government and civil ID programs, and control access to secure areas and networks. With a global network of partners, such as leading system integrators, defense prime contractors and OEMs, Identix serves a broad range of markets including government, law enforcement, gaming, finance, travel, transportation, corporate enterprise and healthcare. More information on Identix can be accessed via the Company web site at http://www.identix.com. Statements in this press release and that relate to future plans, events or performance are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. reflecting management's current expectations, assumptions and estimates of future performance and economic conditions. All forward-looking statements are made in reliance on the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Securities Act of 1933 and the Securities Exchange Act of 1934. Identix cautions investors that forward-looking statements involve risks and uncertainties that may cause actual results to differ materially from those expressed or implied in such statements. Risks and uncertainties include, without limitation, those related to: the availability of funding from government and other customers; the readiness of customers to accept delivery and integration of software and hardware components on a timely basis; the ability of the Company to achieve targeted levels of software and hardware revenue mixes; increasing levels of competition; and other risks identified in the Company's SEC filings. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion